Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Jung Cassie, Chief Operating Officer. Insider active across 1 company, notably Aquestive Therapeutics, Inc.. In total, 9 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €205. History available since 9 March 2023. The latest transaction was disclosed on 9 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Cassie Jung is the Chief Operating Officer at Aquestive Therapeutics, Inc. She oversees the daily operations of the company, focusing on efficiency and innovation. Her role is essential for ensuring performance and growth at Aquestive.